Abstract
The rate of periprosthetic joint infections (PJI) after primary total hip arthroplasty (THA) is approximately 1%. As the number of THAs performed each year continue to increase (550,000 by 2030), a corresponding increase in the number of hip PJI cases is likely to occur. A chronic deep infection may be treated by either chronic suppression, irrigation and debridement, single-stage exchange, or two-stage exchange. In the United States, the gold standard for chronic PJI continues to be a two-stage exchange. The benefit of an antibiotic impregnated cement is that they produce higher local concentrations of antibiotics than systemic intravenous administration.
Hip spacers may be either static or articulating. Static spacers are reserved for cases of massive acetabular bone loss in which an articulating spacer is not feasible. A static spacer consists of a block of antibiotic cement in the native acetabulum and antibiotic coated rod in the femoral canal. Limb shortening, loss of soft tissue planes, and disuse osteopenia and muscle atrophy are all limitations of static spacers. In contrast, articulating spacers fulfill the goals of the interim construct during two-stage exchange which is to enhance eradication of the infecting organism through drug elution, to maintain limb length, to facilitate exposure during revision surgery, and to improve functional mobilization. Articulating spacers may be divided into three general categories based on method of spacer creation: Handmade custom spacers, prefabricated spacers, custom molded spacers (hemiarthroplasty molds and molded stem with cemented all-polyethylene cup). Handmade custom spacers are usually created with K-wire or rush rods coated with antibiotic cement. Handmade spacers are relatively simple to make, they are economical, and the amount and type of antibiotics incorporated can be customised for the infecting organism. Commercially available hemiarthroplasty spacers can be either prefabricated (Spacer G, Exactech, Gainesville. FL) or made intraoperatively (Stage One, Zimmer Biomet, Warsaw, IN) are available in several head and stem sizes. The advantage of prefabricated spacers is that they do not require additional time to mold in the operating room. The downside of prefabricated spacers is that the antibiotic concentration and type is predetermined. A custom molded stem with cemented all-polyethylene cup can be made with off the shelf implants or used as part of a commercially available spacer (PROSTALAC, DePuy Synthes, Warsaw, IN). A common antibiotic/cement combination includes Tobramycin (3.6 g/40 g of cement) and vancomycin (1.5 g/40 g of cement). In all of these spacer constructs, the principles of using a high-elution cement mixed without a vacuum and with high doses of heat stable antibiotics are consistent. Tobramycin works synergistically to improve Vancomycin elution properties and is usually added in higher doses. Overall infection eradication is similar between all categories of spacers and range between 90–97%. Complications after placement of an articulating spacer are often specific to the type of spacer used. Handmade spaces that have K-wires for support are at risk for spacer cement fracture. Spacer dislocation is also a common complication in up to 15% of cases with all types of spacers. In addition, periprosthetic fractures can occur postoperatively in up to 10% of patients. Overall, despite this complication profile, articulating antibiotic spacers have excellent rates of infection eradication and offer improved mobilization in the interim two stage period and reduce operative time, complexity, and morbidity during reimplantation.
